Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

PirB is a functional receptor for myelin inhibitors of axonal regeneration.

Atwal JK, Pinkston-Gosse J, Syken J, Stawicki S, Wu Y, Shatz C, Tessier-Lavigne M.

Science. 2008 Nov 7;322(5903):967-70. doi: 10.1126/science.1161151.

2.

beta1-integrin mediates myelin-associated glycoprotein signaling in neuronal growth cones.

Goh EL, Young JK, Kuwako K, Tessier-Lavigne M, He Z, Griffin JW, Ming GL.

Mol Brain. 2008 Oct 15;1:10. doi: 10.1186/1756-6606-1-10.

3.

Ganglioside inhibition of neurite outgrowth requires Nogo receptor function: identification of interaction sites and development of novel antagonists.

Williams G, Wood A, Williams EJ, Gao Y, Mercado ML, Katz A, Joseph-McCarthy D, Bates B, Ling HP, Aulabaugh A, Zaccardi J, Xie Y, Pangalos MN, Walsh FS, Doherty P.

J Biol Chem. 2008 Jun 13;283(24):16641-52. doi: 10.1074/jbc.M802067200. Epub 2008 Apr 14.

4.

A hypothesis about the relationship of myelin-associated glycoprotein's function in myelinated axons to its capacity to inhibit neurite outgrowth.

Quarles RH.

Neurochem Res. 2009 Jan;34(1):79-86. doi: 10.1007/s11064-008-9668-y. Epub 2008 Apr 12. Review.

PMID:
18408997
5.

Synaptic function for the Nogo-66 receptor NgR1: regulation of dendritic spine morphology and activity-dependent synaptic strength.

Lee H, Raiker SJ, Venkatesh K, Geary R, Robak LA, Zhang Y, Yeh HH, Shrager P, Giger RJ.

J Neurosci. 2008 Mar 12;28(11):2753-65. doi: 10.1523/JNEUROSCI.5586-07.2008.

6.

The inhibition site on myelin-associated glycoprotein is within Ig-domain 5 and is distinct from the sialic acid binding site.

Cao Z, Qiu J, Domeniconi M, Hou J, Bryson JB, Mellado W, Filbin MT.

J Neurosci. 2007 Aug 22;27(34):9146-54.

7.

Myelin-associated glycoprotein reduces axonal branching and enhances functional recovery after sciatic nerve transection in rats.

Tomita K, Kubo T, Matsuda K, Yano K, Tohyama M, Hosokawa K.

Glia. 2007 Nov 1;55(14):1498-507.

PMID:
17705198
8.

Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells.

Mehta NR, Lopez PH, Vyas AA, Schnaar RL.

J Biol Chem. 2007 Sep 21;282(38):27875-86. Epub 2007 Jul 19.

9.
10.
11.

Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers.

Susuki K, Baba H, Tohyama K, Kanai K, Kuwabara S, Hirata K, Furukawa K, Furukawa K, Rasband MN, Yuki N.

Glia. 2007 May;55(7):746-57.

PMID:
17352383
12.

Myelin-associated glycoprotein (MAG): past, present and beyond.

Quarles RH.

J Neurochem. 2007 Mar;100(6):1431-48. Epub 2007 Jan 4. Review.

13.

Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.

Laurén J, Hu F, Chin J, Liao J, Airaksinen MS, Strittmatter SM.

J Biol Chem. 2007 Feb 23;282(8):5715-25. Epub 2006 Dec 21.

14.

Gangliosides as components of lipid membrane domains.

Sonnino S, Mauri L, Chigorno V, Prinetti A.

Glycobiology. 2007 Jan;17(1):1R-13R. Epub 2006 Sep 18. Review. Erratum in: Glycobiology. 2007 Oct;17(10):1030.

PMID:
16982663
15.

Glial inhibition of CNS axon regeneration.

Yiu G, He Z.

Nat Rev Neurosci. 2006 Aug;7(8):617-27. Review.

16.

Targeting Rho to stimulate repair after spinal cord injury.

McKerracher L, Higuchi H.

J Neurotrauma. 2006 Mar-Apr;23(3-4):309-17. Review.

PMID:
16629618
17.

Siglecs--the major subfamily of I-type lectins.

Varki A, Angata T.

Glycobiology. 2006 Jan;16(1):1R-27R. Epub 2005 Jul 13. Review.

PMID:
16014749
18.
19.
20.

Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions.

Yamashita T, Wu YP, Sandhoff R, Werth N, Mizukami H, Ellis JM, Dupree JL, Geyer R, Sandhoff K, Proia RL.

Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2725-30. Epub 2005 Feb 14.

Supplemental Content

Support Center